Loading…
Thursday, August 28, 2014
Current Weather
Loading Current Weather....
HomeNewsMedical
Published: Monday, 6/3/2013

FDA considers lifting safety limits on diabetes pill Avandia

ASSOCIATED PRESS

WASHINGTON  — A former blockbuster diabetes pill that is subject to major safety restrictions may not be as dangerous as once thought, according to the latest analysis of the much-debated GlaxoSmithKline drug.

The Food and Drug Administration is reviewing a new interpretation of Avandia’s heart attack risk, which suggests that the drug is as safe as older diabetes drugs. At a highly unusual meeting this week, the FDA will ask a panel of experts to vote on a range of options for the drug, including lifting safety restrictions on its use.

The safety review is the latest twist in a years-long debate over Avandia that has divided medical experts. The drug was approved in 1999 and grew into a blockbuster, but regulators restricted its use due to unresolved safety questions in 2010.



Guidelines: Please keep your comments smart and civil. Don't attack other readers personally, and keep your language decent. If a comment violates these standards or our privacy statement or visitor's agreement, click the "X" in the upper right corner of the comment box to report abuse. To post comments, you must be a Facebook member. To find out more, please visit the FAQ.

Related stories